Premium
Treatment of severe proliferative retinopathy and diabetic maculopathy
Author(s) -
Ooi Cheong G.,
Hardy Kevin J.
Publication year - 1999
Publication title -
diabetes/metabolism research and reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.307
H-Index - 110
eISSN - 1520-7560
pISSN - 1520-7552
DOI - 10.1002/(sici)1520-7560(199909/10)15:5<373::aid-dmrr60>3.0.co;2-s
Subject(s) - maculopathy , diabetic retinopathy , medicine , blindness , diabetes mellitus , retinopathy , ophthalmology , disease , laser treatment , optometry , endocrinology , laser , physics , optics
Strict blood glucose control, early detection and surveillance of diabetic retinopathy by means of validated screening programmes, and judicious use of laser photocoagulation can greatly reduce the risk of visual loss in diabetes. Some patients however, have aggressive neovascular disease resistant to laser treatment, or present at a late stage with advanced fibroproliferative disease, and may progress rapidly to blindness. In the elderly with Type 2 disease, diabetic maculopathy is more common and requires a different therapeutic approach. The present article describes two diabetic patients and discusses the management of patients with severe proliferative retinopathy or diabetic maculopathy. Copyright © 1999 John Wiley & Sons, Ltd.